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Summary 
IL-lp-converting enzyme (ICE) cleaves pro-IL-lp to 
generate mature IL-lp. ICE is homologous to other pro- 
teins that have been implicated in apoptosis, including 
CED-3 and Nedd-2/Ich-1. We generated ICE-deficient 
mice and observed that they are overtly normal but 
have a major defect in the production of mature IL-1I~ 
after stimulation with lipopolysaccharide. IL-I~ produc- 
tion is also impaired. ICE-deficient mice are resistant to 
endotoxic shock. Thymocytes and macrophages from 
the ICE-deficient animals undergo apoptosis normally. 
ICE therefore plays a dominant role in the generation 
of mature IL-11], a previously unsuspected role in pro- 
duction of IL-le, but has no autonomous function in 
apoptosis. 
Introduction 
Interleukin-ll~ (IL-113)-converting enzyme (ICE) is the cys- 
teine protease that generates the bioactive form of the 
proinflammatory cytokine IL-113 from its biologically inac- 
tive precursor (Black et al., 1988; Kostura et al., 1989). 
ICE is unrelated to previously studied proteases and is 
unusual because of its requirement for Asp in the P1 posi- 
tion of its substrates (Howard et al., 1991; Sleath et al., 
1990). Recently, two genes with possible roles in apop- 
tosis and embryogenesis were discovered that have prod- 
ucts closely related to ICE: the Caenorhabditis elegans 
cell death gene ced-3 (Yuan et al., 1993) and the mamma- 
lian gene Nedd-2/Ich-1 (Kumar et al., 1994; Wang et al., 
1994). ICE, CED-3, and Nedd-2/Ich-1 are members of a 
novel cytoplasmic cysteine protease family. 
Human or rodent ICE is synthesized in cells of the mono- 
cytic lineage as an inactive 45 kDa precursor processed 
proteolytically to generate active enzyme comprising 
polypeptides of 20 kDa (p20) and 10 kDa (pl0) (Miller et 
al., 1993; Thornberry et al., 1992). The 45 kDa precursor 
is the only form of the enzyme readily detected in cells, 
suggesting that processing may be the rate-limiting regu- 
latory step (Ayala et al., 1994). Cleavages of the ICE pre- 
cursor occur at potential ICE-processing sites, and auto- 
processing can occur in vitro (Ayala et al., 1994). It is not 
known, however, whether ICE or another enzyme of simi- 
lar specificity is responsible for the activational processing 
in cells. 
Two groups recently reported the three-dimensional 
structure of human ICE complexed with peptidic inhibitors: 
ICE is a homodimer of catalytic domains, each of which 
contains a p20 and a pl 0 subunit. The catalytic residues in 
the active site are Cys-285 and His-237. Four other amino 
acids whose side chains form the P1 carboxylate-binding 
pocket (Arg-179, Gin-283, Ser-347, and Arg-341), as welt 
the active site Cys and His, are conserved among the 
family members ICE, CED-3, and Nedd-2/Ich-1 (Walker 
et al., 1994; Wilson et al., 1994). 
ICE has attracted interest as a target for novel anti- 
inflammatory drugs, because the cytokine that it activates, 
IL-113, has pleiotropic proinflammatory effects (Dinarello, 
1991). IL-113 is im plicated in the pathophysiology of various 
diseases, including rheumatoid arthritis, septic shock, in- 
flammatory bowel disease, and insulin-dependent diabe- 
tes mellitus (Dinarello and Wolff, t993a). The concept of 
ICE inhibitors as useful drugs, however, is complicated 
by the fact that IL-la, the product of a distinct but closely 
related gene, binds the same receptors as IL-113 and there- 
fore shares its proinflammatory activities (Dinarello and 
Wolff, 1993a). ICE has no known role in regulating the 
production of IL-I(~. Although IL-113 is generally produced 
at much higher levels than IL-l(z in human inflammatory 
diseases (Dinarello and Wolff, 1993a), the potential value 
of ICE antagonists, as compared with receptor antagonists 
that could block both forms of IL-1, remains questionable. 
The role of ICE in the production of mature IL-li~ has 
been demonstrated in cell culture and ex vivo, but is not 
yet well studied in animals. Cells not expressing ICE were 
unable to process pro-I L-113 unless cotransfected with ICE 
cDNA constructs (Cerretti et al., 1992; Young et al., 1988). 
A tetrapeptide aldehyde ICE inhibitor decreased the re- 
lease of mature IL-11~ from stimulated cells in whole human 
blood (Thornberry et al., 1992). Release of small amounts 
of the precursor form, pro-lL-113, was not blocked by the 
same ICE inhibitor and instead may have been stimulated. 
This raises a concern that in vivo other proteases, includ- 
ing elastase and cathepsin G (Black et al., 1988; Hazuda et 
al., 1988), could generate bioactive IL-113 by extracellular 
cleavage of released pro-lL-113. Such activation might be 
particularly likely at sites of inflammation where inflamma- 
tory processes cause secretion of various proteases. 
ICE and other members of the ICE-related protease fam- 
ily have recently been implicated in apoptosis, or program- 
med cell death. Overexpression of ICE in a rat fibroblast 
cell line caused apoptosis, and this could be blocked either 
by the product of bcl-2, a mammalian oncogene that can 
prevent apoptosis, or by crmA, the cowpox virus protein 
that is a specific inhibitor of ICE (Miura et al., 1993). The 
involvement of ICE or a related protease in neuronal cell 
apoptosis was suggested by the observation that microin- 
jection of crmA expression vectors into chicken dorsal root 
ganglion cells blocked apoptosis induced by nerve growth 
factor deprivation (Gagliardini et al., 1994). 
The role of the ICE protease family in apoptosis is of 
great scientific interest, but raises additional doubt about 
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Figure 1. Disruption of ICE Gene by Homolo- 
gous Recombination 
(A) Structure of the ICE gene, the ICE-targeting 
vector, and the mutated locus following homol- 
ogous recombination. Exons are depicted as 
closed boxes and are numbered. Relevant 
restriction enzyme sites are shown. Insertion 
of the neo resistance cassette between the 
Hindlll and Sphl sites in exon 6 leaves 13 n ucle- 
otides downstream. Diagnostic probes used for 
Southern blot analysis are shown. 
(B) Southern blot analysis of tail DNA from wild- 
type, heterozygous, and homozygous ICE- 
deficient animals. DNA was digested with 
BamHI, and blots were hybridized to probe B. 
The wild-type allele is a 15 kb fragment, and 
the mutant allele is an 11 kb fragment. 
the wisdom of selecting ICE as the target for novel anti- 
inflammatory drugs. The genetic approach pioneered by 
Capecchi (1989) makes it possible to address this concern, 
and the others mentioned previously, prior to the availabil- 
ity of inhibitors useful for pharmacologic studies in ani- 
mals. Gene targeting in embryonic stem (ES) cells by ho- 
mologous recombination can be used to generate mice 
with a null mutation in the ICE gene. Such animals would 
be valuable in the studyof the role of ICE and IL-1 in health 
and disease. We report here results with ICE-deficient 
mice. 
Results 
Mice wfth a Nu|l Mutation in the ICE Gene 
A replacement-type targeting vector was constructed as 
outlined in Figure 1. The murine/CEgene is a single-copy 
gene with 10 exons (Casano et al., 1994). Exon 6 encodes 
Cys-284 and Gin-282, amino acids involved in catalysis 
and P1 substrate specificity, respectively. We cloned a 
genomic DNA fragment containing most of the ICE gene 
locus from the 129/Sv mouse strain and introduced be- 
tween the Hindlll and Sphl sites of exon 6 the neomycin 
phosphotransferase (neo) gene under the control of the 
phosphoglycerokinase promoter. This insertion deleted 31 
bp of ICE-coding sequence from the region of the active 
site. The change deleted amino acid Gin-282 and rendered 
out-of-frame the sequence beyond this residue. Introduc- 
tion of a negative selection marker, the herpes simplex 
virus thymidine kinase (tk) gene, at the 3' end of the con- 
struct enabled us to use positive and negative selection 
(Mansour et al., 1988). 
D3 ES cells (Doetschman et al., 1985) were transfected 
with the targeting vector and selected with neomycin and 
gancyclovir• Clones were picked, and DNA was isolated 
from a portion of the cells and screened by Southern blot 
analysis. Three transfection experiments yielded 600 
clones, of which only one clone had undergone homolo- 
gous recombination. Cells from this clone were injected 
into blastocysts from C57BL/6 mice, and the injected blas- 
tocysts were implanted into pseudopregnant B6D2F1 
mice. Ten male chimeras and one female chimera exhib- 
iting more than 70% chimeric agouti patches were born. 
All eleven chimeras were able to transmit he mutation 
through the germline, as determined by polymerase chain 
reaction (PCR). As expected, 50% (86 of 173) of the off- 
spring with agouti coat color derived from mating chimeras 
with C57BL/6 mice were heterozygous for the null muta- 
tion in the ICE gene. Heterozygous animals were mated, 
and approximately 24°/o (89 of 369) of the animals were 
homozygous for the null allele as determined by Southern 
blot analysis of tail DNA (Figure 1B). 
ICE-Deficient Mice Are Overtly Normal 
The ICE-deficient mice developed normally, appeared 
healthy, and were fertile. The average litter size (6.4) of 
ICE-deficient mice bred to date has been normal, with 
equal representation of both sexes. At the time of prepara- 
tion of this manuscript, the oldest mice were 25 weeks 
old, and we had not observed any tumors. 
Histopathological evaluation of all major organs includ- 
ing spleen, lung, heart, kidney, liver, adrenal gland, brain, 
gastrointestinal tract, pancreas, salivary gland, thymus, 
and testis from 8-week-old mice showed no abnormalities. 
ICE-deficient animals had normal numbers of leukocytes, 
erythrocytes, and platelets in the peripheral blood (data 
not shown). Percentages of various T cell subsets and 
B cells in freshly isolated thymuses, spleens, and lymph 
nodes were examined by flow cytometry. There were no 
significant differences in the CD4+CD8 ÷, CD4+CD8 -, 
CD4-CD8 ÷, CD4-CD8-, and B cell populations in any of 
these organs as compared with those of wild-type animals 
(data not shown)• 
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Figure 2. RNA and Protein Expression in ICE-Deficient and Control 
Mice 
(A) Northern blot analysis of ICE RNA expression. RNA was isolated 
from spleens of wild-type (ICE+/+), heterozygous (ICE+l-), and homo, 
zygous (ICE-l-) ICE-deficient animals. Poly(A) + RNA was purified from 
100 p.g of total spleen RNA, then hybridized to a 1.2 kb XhoI-BamHI 
ICE cDNA fragment that recognizes the 1.6 kb ICE mRNA. 
(B) Western blot analysis of ICE protein expression. The major form 
of ICE protein detected is the 45 kDa precursor protein (p45). In addi- 
tion, expression of a polypeptide of105 kDa, detected in the peritoneal 
macrophages, isreduced in ICE (-I-) lysates compared with ICE (+/+) 
and ICE (+1-) lysates. The 105 kDa protein was not detected in COS 
cell transfectants expressing human or murine ICE proteins (data not 
shown). We believe the 105 kDa protein may cross-react with the BBC2 
antibody, or possibly its expression may be regulated by ICE. 
Molecular Confirmation of the Null Allele 
in ICE.Deficient Mice 
We were unable to detect the 1.6 kb ICE mRNA in the 
spleen of ICE-deficient mice by Northern blot analysis (Fig- 
ure 2A), but we did observe a faint band of about 1.0-1.2 
kb in three separate experiments that was also present in 
wild-type and heterozygous mice. Results from extensive 
PCR analysis using exon-specific primers suggest that 
this mRNA may result from cross-hybridization of the ICE 
probe to another member of the ICE superfamily (data 
not shown). As expected, Northern blot analysis using a 
neo-specific probe detected a low level of an mRNA (0.8 
kb) in ICE-deficient and heterozygous mice, but not in wild- 
type littermates (data not shown). In further experiments, 
we extracted RNA from peritoneal exudate cells (PECs) 
and various organs, including brain, lung, heart, liver, ad- 
renal gland, kidney, testis, and thymus, for analysis by 
reverse transcription (RT)-PCR and confirmed the ab- 
sence of full-length ICE transcripts in all of these tissues 
(see Experimental Procedures). 
To investigate ICE protein expression, we raised a poly- 
clonal antibody against recombinant human ICE p32 pro- 
tein (amino acids 120-404; Thornberry et al., 1992) and 
used it to probe Western blots of macrophage cell lysates. 
Macrophages were selected because this cell type prefer- 
entially expresses iCE protein, the predominant form be- 
ing the 45 kDa ICE precursor (p45; Ayala et al., 1994; 
H. A., unpublished ata). We demonstrated in preliminary 
experiments that the antibody detects mouse ICE p45 and 
p32, but noted that it also cross-reacts with a prominent 
mouse protein of 50 kDa. As shown in Figure 2B, p45 ICE 
precursor was readily detectable in macrophages from 
both wild-type and heterozygous littermates, but not in 
those from ICE-deficient mice. As an additional control, 
we showed that NIH 3T3 fibroblasts express the 50 kDa 
mouse protein but no p45 ICE precursor, as expected from 
previous work on the tissue specificity of ICE expression 
(Molineaux et al., 1993). 
Apoptosis Occurs in ICE-Deficient Mice 
As the ICE-deficient mice have no apparent gross abnor- 
malities, we surmised that there were no significant de- 
fects in normal physiological processes involving apoptosis. 
For example, mammary gland involution occurs as a result 
of mammary epithelial cells undergoing apoptosis after 
the lactation period (Strange et al., 1992), and we observed 
that the postlactation involution of mammary glands was 
normal in the ICE-deficient females postpartum on gross 
examination. 
We studied apoptosis induced by in vitro treatment in 
two cell types, macrophages and thymocytes. ATP treat- 
ment induces apoptosis as well as IL-1 release in mouse 
macrophages (Hogquist et al., 1991; Perregaux and Ga- 
bel, 1994). We show in Figure 3A that ATP induced DNA 
fragmentation in C57BL/6 and ICE-deficient macro- 
phages. Thus, the ICE-deficient mice are not critically im- 
paired in ATP-induced macrophage apoptosis. 
Thymocytes undergo apoptosis in vitro after aging or 
exposure to agents such as dexamethasone and y-irra- 
diation. We measured apoptosis by determining the per- 
cent of hypodiploid cells after propidium iodide staining, 
As shown in Figure 3B, the percent of apoptotic ells was 
similar in the ICE-deficient and wild-type littermate mice 
with each of the three methods of induction studied. Simi- 
lar results were obtained by DNA fragmentation analysis 
(data not shown). We also observed that the percent of 
CD4+CD8 + thymocytes, which are known to be susceptible 
to apoptosis, was similar after exposure to the above 
agents (data not shown). 
Macrophages from ICE.Deficient Mice Are 
Defective in IL-11] Processing and Release 
We assessed the processing and release of IL-II~ ex vivo 
using thioglycollate-elicited peritoneal macrophages. Cells 
were stimulated with lipopolysaccharide (LPS) to induce 
expression of pro-lL-113 and then treated with ATP. Mature 
IL-I~ levels in the medium were measured by enzyme- 
linked immunosorbent assay (ELISA). It was reported pre- 
viously that the ATP treatment is necessary to trigger effi- 
cient processing and release of mature IL-I~ from mouse 
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Figure 3. Apoptosis Ex Vivo in Macrophages and Thymocytes from 
ICE-Deficient and Control Mice 
(A) DNA fragmentation induced byATP. Macrophages were stimulated 
with LPS (1 Ilg/ml) for 4 hr then treated with or without ATP (5 mM) 
for 30 min. After emoval of ATP, the cells were cultured for a further 
8 hr, and then DNA was isolated. DNA was extracted from cells by 
using NTE buffer (pH 8.0; 100 mM NaCI, 10 mM Tris-HCI, 25 mM 
EDTA) containing 1% SDS and proteinase K (0.2 mg/ml), as described 
by Trauth et al. (1989). DNA samples were electrophoresed on 20/0 
agarose gels containing ethidium bromide (0.5 p.g/ml); those from 
C57BL/6 macrophages are labeled BL6. 
(B) Apoptosis in thymocytes. Thymocytes from ICE-deficient homozy- 
gous (ICE-l-) and wild-type (ICE+I+) mice w re incubated in vitro at 
37°C for 18 hr with medium alone, medium with I pM dexamethasone, 
or with medium alone after pretreatment with ~(-irradiation (5 Gy). Con- 
trol cells were incubated at 4°C to inhibit apoptosis. The cells were 
then treated with 70% ethanol, RNase, and propidium iodide as de- 
scribed in Experimental Procedures. The stained cells were analyzed 
on a flow cytometer (FACScan) using CellFit software for estimating 
the percentage of hypodiploid cells. 
macrophages (Hogquist et al., 1991; Perregaux and Ga- 
bel, 1994). We confirmed this observation and extended 
it to show that a selective ICE inhibitor, the tetrapeptide 
aldehyde known as Ac -YVAD-a ldehyde,  blocked the re- 
lease of IL-113 in this assay (Table 1). Leupeptin, the tripep- 
tide aldehyde known as LLR-aldehyde,  was used as a 
specificity control and did not inhibit IL-113 release. This 
implies that he ATP-induced processing and release of 
mature IL-113 from mouse macrophages occurs via a mech- 
anism dependent on ICE or another enzyme sensitive to 
the same inhibitor. The ATP treatment also triggers the 
release of I L-1 ~ (Hogquist et al., 1991), and we additionally 
show in Table I that the release and extracellular accumu- 
lation of IL - la  is not significantly inhibited by the ICE inhibi- 
tor Ac -YVAD-a ldehyde  or by leupeptin. 
The stimulated macrophages from ICE-deficient mice 
released barely detectable amounts of mature IL-11{3 (<20 
pg/ml; Table 1 ). This is in striking contrast with the levels of 
2000-4000 pg/ml released from rnacrophages of wild-type 
and heterozygous mice upon stimulation with LPS and 
ATP. Because the ICE-deficient macrophages failed to re- 
lease mature IL-113 but nevertheless underwent apoptosis 
after the ATP treatment (see Figure 3A), this experiment 
also shows that apoptosis and release of mature IL-113 are 
independent processes. Interestingly, the extracellular ac- 
cumulation of IL- I~ was also markedly reduced from the 
ICE-deficient macrophages, to a level of about 25% of that 
from wild-type and heterozygous cells. This reduction was 
surprising, given that the Ac -YVAD-a ldehyde  ICE inhibi- 
tor failed to inhibit the extracellular accumulation of IL- I~ 
from control macrophages. 
Immunoprecipitations of IL- I~ and IL-113 proteins were 
done on cell lysates and supernatants from peritoneal 
macrophages pulsed with [35S]methionine (Figure 4). Anal- 
ysis of the cell lysates showed that induction by LPS of 
the 31 kDa IL- I~ and 34 kDa IL-113 precursors was similar 
in C57BL/6 and ICE-deficient macrophages. We also ob- 
tained similar results with wild-type and heterozygous 
macrophages (data not shown). Immunoprecipitations 
from the supernatants confirmed the ELISA results re- 
ported for IL-lcz and IL-11~ in Table 1. No 17 kDa mature 
IL-11~ was detected in the supernatant of ICE-deficient 
macrophages after the 30 min treatment with ATP. A trace 
level of 17 kDa mature IL-I~ was found in the supernatant 
of ICE-deficient cells upon further culture for 3 hr after 
removal of the ATP. Immunoprecipitations of IL-1 e showed 
Table 1. IL-le and I~ Release from ICE (+/+), ICE (+/-), and ICE (-/-) Macrophages 
IL-1 ~ (pg/ml) IL-11~ (pg/ml) 
Stimulation ICE (+/+) ICE (+/-) ICE (-I-) ICE (+1+) ICE (+/-) ICE (-I-) 
LPS 5845 ± 860 3511 ± 313 1199 ± 118 4428 ± 36 1879 ± 184 <20 
LPS plus YVAD 4162 ± 399 3135 ± 243 941 ± 30 833 ± 40 332 ± 60 <20 
LPS plus Leupeptin 4241 ± 79 2971 ± 388 938 ± 12 4013 ± 262 2796 ± 123 <20 
Thioglycollate-elicited macrophages were stimulated in vitro with LPS (1 p.g/ml) and ATP (5 raM) (see Experimental Procedures). Levels of IL-l~ 
and IL-113 in the medium at 3 hr after ATP addition were measured by ELISA. Where indicated, Ac-YVAD-CHO (YVAD) or leupeptin were present 
in the medium at 50 I~M. ICE (+/+), ICE (+/-), and ICE (-/-) macrophages timulated without LPS released <15 pg/ml IL-le and <10 pg/ml IL-113. 
The data shown are averages ± variation for supernatants from duplicate w lls of macrophages. Similar results were obtained in three separate 
experiments. 
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Figure 4. IL-lct and IL-II3 Production by Mac- 
rophages from ICE-Deficient and Control Mice 
Macrophages were stimulated with or without 
LPS (1 p.g/ml) for 4 hr and pulse-labeled with 
[~S]methionine during the last hour (see Exper- 
imental Procedures). Cell lysates were pre- 
pared before addition of ATP (time zero of the 
chase, t = 0 rain). Supernatants were collected 
after the 30 min ATP treatment (t = 30 rain) and 
after a further 3hr culture following removal of 
ATP (t = 3 hr). Levels of IL-1 a and IL-113 in the 
supernatants were quantitated by ELISA and 
were found to be similar to those shown in Ta- 
ble 1 (data not shown). In addition, cell lysates 
were prepared at t = 3 hr and irnmu noprecipita- 
tions of IL-I~ and IL-I~ performed (data not 
shown). This confirmed efficient induction of 
pro-lL-l(~ and pro-lL-l~ in the cells from which 
the media supernatants were harvested. Ly- 
sates from C57BL/6 macrophages are labeled 
BL6. 
that, at the 3 hr time point, the level of the 15 kDa mature 
form of IL-l~z, as well as the level of the released 31 kDa 
precursor form, was significantly reduced in the superna- 
tant of ICE-deficient cells compared with that in the super- 
natants of wild-type and heterozygote controls. 
We conclude that macrophages from ICE-deficient mice 
have an extreme but not absolute defect in the production 
of mature IL-113. In addition, there is an unanticipated ma- 
jor reduction in release and extracellular accumulation of 
IL-I~. 
ICE-Deficient Mice Survive LPS-lnduced Septic 
Shock and Produce No Detectable IL-lJ~ 
or IL- la In Vivo 
Injection of high doses of LPS intraperitoneally into mice 
induces the massive systemic release of proinflammatory 
cytokines such as both types of IL-1 and TNFm These 
cytokines are important in the pathogenesis of systemic 
inflammatory response syndrome (SIRS) and septic shock, 
which develops in the animals and results in their death 
(Dinarello et al., 1993b). 
To investigate whether the ICE-deficient mice have a 
defect in production of cytokines in vivo, and to ask 
whether such a defect would lead to decreased SIRS, we 
administered LPS to mutant and control mice and then 
measured both survival and cytokine levels in plasma. We 
used a high dose of LPS (800 I~g) that was found to cause 
100% lethality in C57BL/6 mice in preparatory studies. 
Preliminary experiments, using wild-type C57BL/6 and 
heterozygous ICE-deficient mice, showed high levels of 
IL-113, IL-la, TNF~, and IL-6 in plasma 4 hr after high dose 
LPS treatment (data not shown). Therefore, ICE-deficient 
mice (and wild-type littermates) were bled 4 hr after LPS 
injection. The plasma from groups of mice of each geno- 
type and sex were pooled to obtain sufficient plasma for 
analysis. Representative data from one experiment are 
shown in Table 2. IL-113 was undetectable in the plasma 
of the ICE-deficient mice, although the cytokine was de- 
tectable at high levels in the control mice. Note that the 
results are listed separately by gender, because we found 
that male mice consistently had much lower concentra- 
tions of IL-l~ and IL-l~ after LPS injection than females. 
The concentrations of TNF~ and IL-6 in the ICE-deficient 
mice were also moderately decreased compared with 
those of controls. Most surprisingly, we did not detect IL-la 
in the plasma of ICE-deficient mice. IL-I~ levels in wild- 
type female mice were approximately 250 pg/ml. Given 
the sensitivity of the ELISA that we used (30 pg/ml), we 
infer from these data that IL-I~ levels in the ICE-deficient 
mice were more than 5-fold reduced compared with those 
of control animals after LPS injection. 
Survival data are presented in Figure 5. All wild-type 
mice in three experiments uccumbed to the high dose of 
LPS within 30 hr. Although we had noted a gender-specific 
difference in cytokine levels, there was no corresponding 
difference in time to death. By contrast, the ICE-deficient 
mice were highly resistant o the lethal effects of LPS, with 
all animals surviving beyond 30 hr and 70% of the mice 
surviving after 7 days. The first deaths of ICE-deficient 
mice occurred at around 45 hr in each experiment. ICE- 
deficient mice demonstrated signs of endotoxemia fter 
LPS treatment, including lethargy, piloerection, and mild 
febrile shaking for the first few days after the LPS injection. 
These signs were milder than those observed in wild-type 
mice and perhaps can be attributed to the effects of TNFa 
in these animals. 
Discussion 
Gene targeting is a valuable method to evaluate the role 
of various genes in host defense and disease. Mice with 
disruptions in cytokine-related genes such as those for 
IL-2 (Schorle et al., 1991), IL-4 (KLihn et al., 1991), IL-6 
(Kopf et al., 1994), IL-10 (KLihn et al., 1993), IFNy (Dalton 
et al., 1993), IFNy receptor (Huang et al., 1993), TNF~ 
(Togni et al., 1994), and p55 TNF receptor (Pfeffer et al., 
1993; Rothe et al., 1993) have been created. This report 
describes ICE-deficient animals; as yet we know of no pub- 
lished studies on the generation of mice deficient in IL-I~ 
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Table 2. Plasma Cytokines in Endotoxic Shock 
Females Males 
Cytokines (pg/ml) ICE (+/+) ICE (- I - )  ICE (+/+) ICE (- I - )  
IL-I~ 493 ± 34 <20 126 ± 2 <20 
IL-I~ 253 ± 18 <30 62 ± 8 <30 
TNF~ 884 ± 56 627 ± 150 821 ± 12 562 ± 78 
IL-6 520 ± 71 296 ± 16 209 ± 49 179 ± 12 
ICE-deficient mice (ICE [ - / - ] )  and wild-type mice (ICE [+/+]) were bled from the retro-orbital plexus 4 hr after LPS administration. The plasma 
from four mice of each gender and genotype was pooled for estimation of cytokines by ELISA. The data are means _+ SD of two to four replicates 
from one pooled sample from each group. 
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DAYS AFTER LPS 
Figure 5. Survival of ICE-Deficient and Control Mice after Injection 
with High Doses of LPS 
Survival of age-matched ICE-deficient homozygous (ICE-/-) and wild- 
type (ICE+/+) mice after injection with 800 p.g of LPS intraperitoneally 
on day 0. The data shown are combined from three independent experi- 
ments, with a total of 28 ICE (-I-) and 19 ICE (+/4-) mice. The survival 
of ICE (-I-) mice was significantly enhanced (p < 0.001 by %2 test) as 
compared with the ICE (+/+) mice. 
or IL-1 p. Therefore, the present work provides a significant 
example of mice with defects in IL-I. 
The ICE-deficient mice are overtly normal. They have 
no apparent anatomical or developmental abnormalities 
as judged by gross examination of neonates and adults, or 
by histological analysis of all major organs. Hematopoietic 
and lymphoid cells appeared normal in number and distri- 
bution in the peripheral blood and lymphoid organs. We 
observed no evidence of any disease in the mice; sponta- 
neous tumors have so far not occurred even in the oldest 
animals (25 weeks of age). The absence of any abnormal- 
ity or pathology contrasts with results of null mutations in 
other cytokine genes, such as the lack of lymph nodes in 
TNFI3-deficient mice (Togni et al., 1994) and the occur- 
rence of ulcerative colitis in IL-2- and IL-lO-deficient mice 
(KShn et al., 1993; Sadlack et al., 1993). One caveat, how- 
ever, is that our animals are still young and have never 
been removed from specific pathogen-free (SPF) condi- 
tions. Their susceptibility to infectious agents that would 
be present in a less controlled normal environment is un- 
known. In IL-10-deficient mice, inflammatory bowel dis- 
ease was less severe in animals maintained under SPF 
conditions. 
Analysis of the ICE-deficient mice at the DNA, RNA, and 
protein levels confirmed that we had inactivated ICE gene 
function by targeted isruption. We did detect, at low level, 
an mRNA smaller than the major ICE transcript in splenic 
RNA from both the ICE-deficient and wild-type mice. This 
may be the product of an ICE-related gene, and we are 
now attempting to clone it for comparative analysis with 
ICE and other known family members. 
While ICE-deficient mice have no gross abnormalities, 
they have a profound defect in their capacity to produce 
mature IL-113. Peritoneal macrophages from the mutant 
mice, stimulated ex vivo by treatment with LPS and ATP, 
released only barely detectable amounts of mature IL-113 
(less than 1% of control levels as measured by ELISA of 
cell supernatants). There was no decrease in pro-lL-113 
synthesis or release as observed by immunoprecipitation. 
The small amount of mature IL-113 released by the macro- 
phages from mutant mice was of the correct molecular 
weight, suggesting that specific cleavage of pro-lL-113 may 
occur in the mutant cells, although at a very low level. 
Macrophages from mice heterozygous for the ICE muta- 
tion produced about half the mature IL-113 level of those 
from wild-type mice, implying that the rate of IL-113 release 
from cells is proportional to ICE gene dosage. This sug- 
gests that ICE activity could be the rate-limiting step in 
regulating the amount of mature IL-113 released from stimu- 
lated macrophages. 
We confirmed the defect in IL-113 production in vivo by 
observing that plasma from ICE-deficient mice injected 
with a high dose of LPS had undetectable levels of mature 
IL-11~. ICE is thus required for the dominant pathway of 
IL-113 maturation in response to LPS. The very low level 
of IL-11~ production detected in cells ex vivo from the ICE- 
deficient mice must be generated by a different mecha- 
nism, possibly by extracellular proteolysis of pro-lL-113 re- 
leased from cells. Alternatively, another member of the 
ICE protease family may inefficiently process pro-lL-l[3, 
and experiments to test this possibility are in progress. 
An additional question we planned to address with ICE- 
deficient mice was the relative importance of IL-I~ and 
IL-I~ in inflammation. Our presumption was that ICE- 
deficient animals would be blocked in IL-1 I~ but not in IL-1 (~ 
production, and therefore the animals would serve as mod- 
els for the action of IL-lp-selective drugs. To our surPrise, 
ICE-deficient mice also have a significant defect in IL-la 
production: IL-1 ct production ex vivo by macrophages from 
these mice was only 20%-25% of wild-type levels after 
stimulation with LPS and ATP. IL-I~ was not detected in 
the plasma of LPS-treated mutant mice, implying at least 
Characterization of ICE-Deficient Mice 
407 
a 5-fold decrease in accumulation in vivo. The defect in 
I L-I~ production was unexpected, because earlier studies 
suggested that ICE does not process pro-lL-l~ (Howard 
et al., 1991). Further, we show here that the ICE inhibitor 
Ac-YVAD-aldehyde does not appreciably prevent extra- 
cellular accumulation of IL-I~ from stimulated cells. Pro- 
cessing of pro-lL-la is thought to be accomplished by a 
calpain-like IL-lm-converting enzyme (Carruth et al., 1991; 
Kobayashi et al., 1990). 
There are several possible explanations for the reduced 
I L-1 ~ release in ICE-deficient m ice. Our preliminary experi- 
ments suggest that mature IL-113 does not regulate the 
release of IL-I~ from LPS-stimu{ated cells (data not 
shown). Therefore, we favor the idea that ICE is involved 
directly in the processing of IL-I~, its release, or both. 
Such roles could be independent of the catalytic activity 
of ICE and instead involve a cofactor function in IL-I~ 
maturation. Further experiments are in progress to study 
this mechanism. 
Another reason for developing ICE-deficient mice was 
to assess the potential role for this enzyme in apoptosis. 
Our results clearly prove that animals without ICE have 
no readily demonstrable defect in apoptosis. The absence 
of apparent abnormalities in the ICE-deficient mice argues 
strongly against a necessary function for ICE in apoptosis. 
If ICE played a required role in apoptosis during develop- 
ment, the ICE-deficient mice should have gross abnormali- 
ties in brain, gut, lymphoid, and neuronal tissues. At the 
cellular level in lymphoid tissues, there were no abnormali- 
ties in the numbers of B cells or T cell subsets, whereas 
abnormalities in B and T cell populations were reported 
in lymphoid tissue of mice transgenic for bcl-2 (McDonnell 
et al., 1989; Sentman et al., 1991), a gene known to sup- 
press apoptosis (Vaux et al., 1988). Macrophages and thy- 
mocytes from ICE-deficient mice retained their capacity 
to undergo apoptosis upon ex vivo stimulation by several 
different signals. This contrasts with mice that are p53 
deficient or overexpress Bcl-2, both of which have defects 
in their apoptotic pathways that are discernible in vitro 
(Lowe et al., 1993; Sentman et al., 1991). 
Transfection of cDNA vectors that encode ICE into a rat 
embryo fibroblast cell line induced apoptosis (Miura et al., 
1993). This does not prove that ICE is a normal element 
in the apoptotic pathway, because unregulated ICE ex- 
pression could be replacing a function normally served by 
a related enzyme with similar substrate specificity. Other 
members of the ICE family, namely the C. elegans gene 
ced-3 (Yuan et al., 1993) and human NEDD-2/ICH-1, also 
caused apoptosis (Kumar et al., 1994; Wang et al., 1994) 
when transfected into rodent fibroblasts. While the natural 
substrates of CED-3 and NEDD-2/ICH-1 are not known, 
the conservation of all of the amino acids whose side 
chains determine the P1 substrate-binding pocket in the 
ICE X-ray structure (Walker et al., 1994; Wilson et al., 
1994) suggests that all ICE family members are Asp- 
specific proteases. Granzyme B, a serine protease that is 
unrelated to ICE but shares the specificity for cleaving 
substrates after aspartyl residues, also induces apoptosis 
and plays a critical rote in the cytotoxicity of natural killer 
cells and cytotoxic T cells (Hudig et al., 1993). These con- 
siderations uggest to us that there is a common substrate 
present in cells that, when cleaved by an appropriate Asp- 
specific protease, can cause apoptosis. ICE can accom- 
plish such cleavage if overexpressed in fibroblasts, but 
the results with ICE-deficientmice argue that ICE is not 
involved in normal apoptotic pathways. We cannot, how- 
ever, exclude the more complex theory that there are two 
or more proteases that function redundantly in the induc- 
tion of apoptosis such that elimination of ICE alone has 
no effect. To test this possibility would require additional 
mice deficient in ICE homolog genes, and the mating of 
strains to produce mice with mutations in two or more 
family members. 
Gagliardini et al. (1994) showed that transfection with 
crmA, a cowpox virus serpin known to inhibit ICE (Ray et 
al., 1992), could prevent apoptosis of chicken dorsal root 
ganglion neurons induced by nerve growth factor depriva- 
tion in vitro. This result does not conflict with the absence 
of an apoptosis defect in ICE-deficient mice if one pro- 
poses that crmA was acting by inhibiting an ICE homolog 
rather than ICE itself. The possibility that crmA may have 
inhibited an ICE homolog involved in neuronal apoptosis 
is further supported by the recent identification of a novel 
chicken protease, priCE, that resembles ICE but is impli- 
cated in apoptosis (Lazebnik et al., 1994). 
The most striking result reported in this paper is that 
ICE-deficient mice are markedly resistant to the lethal ef- 
fects of endotoxin. We used a high dose of LPS to induce 
SIRS. Whereas all the wild-type mice died within 30 hr 
after injection, all ICE-deficient mice studied so far have 
survived for at least 45 hr, and only 30% of animals died 
during the next 5 days. No IL-lJ3 or IL-la was detectable 
in the plasma of the mutant mice. The levels of TNF~ 
and IL-6 were somewhat reduced compared with those in 
wild-type mice. The reasons for the delayed mortalities 
in ICE-deficient mice injected with LPS are unclear. The 
deaths may not relate directly to LPS-induced pathology. 
Rather, they may reflect other consequences of dimin- 
ished IL-1 production, for instance, increased susceptibil- 
ity to infection, either from endogenous gut flora or asso- 
iated with the experimental protocol, which involved 
retro-orbital bleeding to obtain blood samples for cytokine 
measurements. The survival of ICE-deficient mice after a 
high dose of LPS is similar to the protection afforded by the 
IL-1 receptor antagonist (IL-1RA) (Alexander et al., 1991). 
The ICE-deficient mice are thus different from the IFN~, 
receptor-deficient and p55 TNF receptor-deficient mice, 
which are susceptible to high dose LPS-induced lethality 
(Car et al., 1994; Rothe et al., 1993). 
Current hypotheses for the pathogenesis of septic shock 
are that microbial products such as LPS induce massive 
production and release of TNF~, which in turn induces 
IL-1 production and release by macrophages (Dinarello et 
al., 1993b). In human sepsis, the species of IL-1 detectable 
in plasma is exclusively IL-I~. Both TNF~ and IL-1 have 
profound effects on vascular endothelial cells, leading to 
cell adhesion, vascular leakage, and shock. Neutralization 
of either TNFc~ or IL-113 prevents lethality in animal models 
of sepsis (Dinarello et al., 1993b). The present studies 
extend these observations and suggest that ICE inhibitors 
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could be useful in reducing mortal ity in human sepsis. 
Moreover,  as S IRS is an ext reme and acute example  of 
systemic inf lammation,  ICE inhibitors may have therapeu-  
tic potential in other  in f lammatory diseases,  such as rheu- 
matoid arthritis, in which IL-11~ plays a signif icant role. 
Experimental Procedures 
Construction of the ICE-Targeting Vector 
A partial murine ICE cDNA was isolated from a mouse macrophage 
cDNA library (Stratagene) by using a full-length human ICE coding 
sequence (provided by Dr. T. Ghayur). This cDNA was used to screen 
two mouse genomic DNA ~. phage libraries made from the 129/$v 
strain of mouse (Stratagene; J1 library provided by Dr. R. Jaenisch). 
The isolated murine ICE genomic clones were then subcloned into a 
plasmid vector, pBluescript (Stratagene), for restriction mapping, par- 
tial DNA sequencing, and construction of the targeting vector. 
The ICE-targeting vector was constructed by using the plasmid 
pPNT (provided by Dr, R. Mulligan). A 2.2 kb SphI-Notl ICE fragment 
containing part of exon 6 and sequences downstream was isolated 
and subcloned into pBluescript at the BamHI and Notl sites by use 
of a SphI-BamHI adaptor made with two oligonucleotides with the 
following sequences: 5'-GATCCGAACCCCTTCGCATG-3' and 5'- 
CGAAGGGGTTCG-3', The 2.2 kb ICE fragment was then isolated as 
a BamHI-Notl fragment and the Notl end filled in with Klenow. This 
fragment was inserted into pPNT at the BamHI and EcoRI sites after 
filling in the EcoRI site, thus positioning it right after the neo gene on 
the 5' end and right before the tk gene at the 3' end. A 6.5 kb Bglll- 
Hindlll fragment containing ICE upstream sequences as well as exons 
1-5 and ending in the middle of exon 6 was subcloned into pBluescript 
and subsequently excised out as a NotI-Xhol fragment and inserted 
5' to the nee gene in the pPNT3'ICE vector. In the final targeting con- 
struct, a 31 bp ICE sequence contained within the Hindlll and the Sphl 
sites was deleted from exon 6 (Figu re 1A). This plasmid was linearized 
by Notl digestion. 
ES Cell Culture and Transfection 
D3 ES cells (supplied by R. Hynes) were cultured on a neomycin- 
resistant embryo fibroblast feeder layer grown in Dulbecco's modified 
Eagle's medium supplemented with 15% fetal calf serum, 2 mM gluta- 
mine, penicillin (50 U/ml), streptomycin (50 p_g/ml), nonessential amino 
acids, 100 p.M ~-mercaptoethanol, and 500 U/ml leukemia inhibitory 
factor. Medium was changed daily, and D3 cells were subcultured 
every 3 days. D3 cells (8 x 106) were transfected with 25 I~g of linear- 
ized plasmid by electroporation (25 p.F capacitance and 400 V) and 
cultured for the first 5 days in 2 x 10 -8 M gancyclovir and 300 p.g/ml 
neomycin and for the last 3 days in neomycin alone. Clones were 
expanded, some cells were frozen down, and DNA was isolated from 
the rest. 
Southern Blot Analysis 
ES cells or 0.5 cm of tail tissue were iysed in 100 mM Tris-HCI (pH 8.5), 
5 mM EDTA, 0.2% SDS, 200 mM NaCI, and 100 i~g/ml of proteinase K. 
DNA was recovered by isopropanol precipitation and solubilized in 10 
mM Tris-HCI (pH 8.0) and 0.1 mM EDTA. After digestion with EcoRV 
and Haell or BamHI alone, the DNA was resolved on a 0.8% agarose 
gel, blotted onto Hybond-N membrane, and hybridized at 65°C with 
probe A or probe B, respectively, described below. Blots were washed 
with 40 mM sodium phosphate buffer (pH 7.2), 1 mM EDTA, and 10/0 
SDS at 65°C and exposed to X-ray film. Occurrence of homologous 
recombination could be confirmed readily, owing to the introduction 
of several Haell sites and a Bam HI site by the neo gene into the mutated 
exon 6 of the ICE gene. DNA was digested with EcoRV-Haell and 
analyzed by use of probe A (Figure 1A), which binds a region proximal 
to the 5' end of the targeting vector. The wild-type allele gave a frag- 
ment of approximately 13 kb and the mutant allele approximately 12 
kb (data not shown). DNA was also digested with BamHI and analyzed 
by use of probe B (Figure 1B), which binds a region distal to the 3' 
end of the vector. In this case, the wild-type allele gave a fragment 
of about 15 kb and the mutant allele a fragment of about 11 kb. 
Generation of ICE-Deficient Mice 
C57BL/6 female and male mice were mated, and blastocysts were 
isolated at 3.5 days of gestation. Cells from clone 164 were injected, 
10-12 per blastocyst, and 7-8 blastocysts were implanted in the uterus 
of a pseudopregnant B6D2F1 female. Pups were delivered by cesarian 
section on day 18 and placed with a foster BALB/c mother. Male and 
female chimeras were mated with female and male C57BL/6 mice, 
respectively, and germline transmission was determined by the agouti 
coat color. After genotyping by Southern blot analysis, the heterozy- 
gous animals were mated with each other to generate homozygous 
mutant mice. 
Northern Blot Analysis and RT-PCR Analysis of RNA 
RNA was extracted from various organs of the mice by using 4 M 
guanidinium thiocyanate followed by centrifugation through 5.7 M 
CsCI (Sambrook et al., 1989). Poly(A) + RNA was isolated from 100 p.g 
of total RNA and resolved on 1% formaldehyde agarose gels and 
blotted onto Biodyne nylon membrane (ICN Pharmaceuticals). Blots 
were hybridized with a 32P-labeled 1.2 kb XhoI-BamHI ICE cDNA frag- 
ment. Alternatively, first-strand cDNA was synthesised through use of 
the GIBCO BRL Superscript system. PCR was performed with the 
Perkin Elmer Thermal Cycler and the following conditions: 95°C for 
30 s (1 cycle); 94oC for 30 s, 54°C for 30 s, 72°C for 1 rain (30 cycles); 
and 72°C for 5 rain (1 cycle). PCR products were visualized by ethidium 
bromide on agarose gels. 
The primers used and the results obtained are shown in Table 3. 
Western Blot Analysis 
Mice 8 weeks old were injected intraperitoneally with 1.5 ml of thiogly- 
collate medium (Sigma). PECs were harvested 4-5 days later. Macro- 
phages were purified from the PECs by adherence to plastic in RPMI 
1640 without serum for 2 hr at 37°C. Macrophage cell lysates were 
separated on 10% SDS-polyacrylamide gels, then transferred to nitro- 
cellulose filters (Amersham). Filters were probed with BBC2, a rabbit 
antibody to recombinant human ICE p32 protein (amino acids 120- 
404), at 1 ~g/ml in PBS with 5% dried milk and 0.2% Tween 20. 
Detection was carried out by use of a secondary horseradish peroxi- 
dase-linked anti-rabbit antibody (Amersham) and the Amersham en- 
hanced chemiluminescence system. 
The recombinant human ICE p32 protein was expressed in Esche- 
richia coil and purified, essentially as described for ICE p20 and pl0 
proteins by Walker et al. (1994). The rabbit polyclonal antibody raised 
to ICE p32, BBC2, was characterize d by using COS cell transfectants 
expressing human ICE p32 and murine ICE p32 proteins, respectively. 
Table 3. RT-PCR Analysis of ICE mRNA Expression 
5' Primer 3' Primer +/+ +/-  - / -  
CCTGAGGGCAAAGAGGAAGC (miCE exon 2) TCTGAAGGATTTTCT]-I'CCA (mICE exon 4) + + + 
A I I I I CTTTCACTTTCACGG (mICE exon 5) + + + 
AAGGAAAGTACTGTAAGAAG (exon 6, 5' of nee insertion) + + + 
CATGCCTGAATAATGATCACC (exon 6, 3' of neo insertion) + + - 
GAGCAGAAAGCAATAAAATC (miCE exon 7) + + - 
AGCCTAAAI-rCTGGTTGTTC (miCE exon 9) + + - 
GGCACGAI-rCTCAGCATAGG (mICE exon 10) + + - 
See text of this section for details. 
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These experiments howed that BBC2 recognized both human and 
murine ICE p32 proteins. In addition, the antibody cross-reacted with 
an endogenous 50 kDa COS cell protein in mock-transfected as well 
as ICE p32-transfected COS cells. Detection of the 50 kDa protein 
was not diminished by preclearing lysates with preimmune serum from 
the same rabbit used to generate BBC2. 
IL-1 Release 
Peritoneal macrophages were stimulated with LPS (E. coil strain O111: 
B4; Calbiochem) at 1 ~g/ml in RPMI 1640 with 10% fetal calf serum 
for 4 hr at 37°C, then treated with ATP (5 mM, Sigma) for 30 rain, as 
described by Hogquist et al. (1991). Fresh medium was added and 
the cells cultured for a further 3 hr. In some experiments, Ac-YVAD- 
aldehyde (Bachem Bioscience) or leupeptin (Sigma) was present in 
the medium at 50 p_M. The levels of I L-1 ~ and IL-I~ in the medium were 
measured by ELISA kits from Genzyme Corporation and PerSeptive 
Diagnostics, respectively. 
In preliminary experiments, we examined the kinetics of ]L-I(~ and 
IL-II3 release. There is a delay in release of IL-lct relative to IL-I~. 
Maximal release of IL-la occurs between 2 and 3 hr after removal of 
ATP (data not shown). Cell viability was assesed by trypan blue exclu- 
sion and was/>90% at the 3 hr time point. 
Immunoprecipitation 
Peritoneal macrophages were treated with or without LPS (1 l~g/ml) 
for 4 hr and pulse-labeled with [3SS]methionine (200 ~Ci/ml, Du Pont) 
during hour 4. Labeled cells were washed with PBS and treated with 
ATP (5 raM) for 30 min, the medium was collected, and fresh medium 
was added and then harvested after a further 3 hr chase. Cell lysates 
were prepared either before addition of ATP (time zero of chase) or 
at 3 hr after ATP treatment (end of chase) by extraction with 1% Triton 
X-100, 50 mM Tris-HCI (pH 8.0), 150 mM NaCI plus protease inhibitors 
(1 mM EGTA, 25 mM iodoacetamide, 100 p~g/ml aprotinin, 100 p.g/ml 
leupeptin, 10 i~g/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride 
[PMSF], all from Sigma). Media samples were adjusted to 1% Triton 
X-10O, 50 mM Tris-HCI (pH 8.0), plus protease inhibitors. In addition, 
a fraction of the media samples was saved to measure levels of I L-1 
and IL-1 ~ by ELISA (data not shown). Cell lysates and media samples 
were precleared with normal goat immunoglobulin (Sigma) and protein 
G-Sepharose (Sigma). Immunoprecipitations were performed with 
goat antibodies specific for mouse IL-I~ or IL-I~ (R and D Systems). 
Immunoprecipitates bound on protein G-Sepharose were washed five 
times with 1% Triton X-100, 50 mM Tris-HCI (pH 8.0), 150 mM NaCI, 
and 1 mM PMSF, then analyzed on 12% SDS-polyacrylamide gels. 
Similar results were obtained in two separate experiments. 
Thymocyte Apoptosis 
Thymocytes were incubated in RPMI with 10% fetal calf serum and 
supplements at a coneentration of 2 x 106 cells/ml in 48-well tissue 
culture plates (Costar), at 37°C in a 5°/0 CO2 incubator. They were 
incubated with or without dexamethasone at 10 -6 M or were y-irradiated 
with 5 Gy prior to culture. Some cells were kept at 4°C to prevent 
apoptosis. The cells cultured in vitro were collected after 18 hr for 
analysis of apoptosis. Cells were fixed with 70% ethanol for 1 hr at 
4°C, washed, and then treated with RNase (0.5 mg/ml) and propidium 
iodide (50 p~g/ml) as described (Nicoletti et al., 1991). The cells were 
stored in the dark at 4°C until they were analyzed on the FACScan 
flow cytometer for propidium iodide fluorescence by use of CellFit 
software. The percent of cells with hypodiploid staining of the nuclei 
was taken as a measure of apoptosis. 
LPS-lnduced Septic Shock 
Mice (8-10 weeks old) were injected with 800 ~g of LPS from E. coil 
serotype O111 :B4 (Calbiochem) intraperit0neally to induce high dose 
LPS-induced septic shock. The dose was based on published results 
and our own results obtained from studies on LPS-induced septic 
shock in C57BL/6 mice. The mice were monitored for signs of endotox- 
emia and lethality at least twice daily for 4 days and periodically there- 
after. The animals were bled retro-orbitally ( -  100 Id) 4 hr after LPS 
injection, and plasma was pooled from animals of the same sex and 
genotype to obtain sufficient sample volume; it was then analyzed for 
cytokines. Cytokine estimations of murine IL-II~, IL-I~, and TNFa were 
done with ELISA kits from Genzyme Corporation. ELISA kits for murine 
IL-6 estimation were from Biosource international. Using the methods 
described in the kits and the dilutions used for the assays, we found 
the detection limits for IL-I~, and IL-l~ to be 20 pg/ml and 30 pg/ml, 
respectively. 
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